Microdosing GLP-1 Drugs: Hope, Hype, and the Search for Healthy Aging

By Emeran Mayer, MD

GLP-1 drugs like semaglutide have transformed diabetes and weight-loss care, but a new “microdosing” trend is sparking controversy. Are tiny doses a breakthrough for healthy aging or just hype? Explore what the science really says.
All Blog Posts

CONTENT for MEMBERS ONLY

If you’re already a member, please log in to access our collection of articles.

New here? Join our community by selecting one of our free or paid membership options and start enjoying exclusive content today.

Login
Sign Up

Premium Articles

Already a Paid Member? Login to view this content.

Login

New Here? Enjoy access to Dr. Mayer’s Premium Articles by signing up for one of our Paid Memberships. 

Membership Includes: 

  • Ask Me Anything (AMA) Access 
  • Premium Articles 
  • Access to our Recipe Hub 
  • E-Books & Exclusive Discounts
Sign Up


Premium article.

Previous Post:
Intermittent Fasting May Be More Effective Than Daily Calorie Restriction
Next Post:
How to Optimize Your Sleep: A Science-Backed Guide